No abstract

No abstract

The water buffalo is an important domestic animal worldwide, and the local Buffalypso variety was developed in Trinidad to have improved beef qualities. Brucellosis was diagnosed in Trinidad and Tobago during 1998 in both cattle and domestic water buffalo (Bubalus bubalis) populations. Brucellosis in the latter species is caused by infection with Brucella abortus, similar to bovine brucellosis. Control of brucellosis is of paramount importance to preservation of the genetic diversity of these animals in Trinidad, and this has been complicated by differences in the epidemiology of water buffalo and bovine brucellosis. Some diagnostic tests do not have comparable accuracy between the two species, and the RB51 vaccine does not adequately protect against infection in water buffalo. The water buffalo in Trinidad may also be more resistant to infection than cattle. Development of effective vaccination protocols is key to brucellosis control in Buffalypso in Trinidad, and prohibitions on import of virulent B. abortus strains for vaccine efficacy studies has impeded progress in this area. These Trinidadian strains are of variable virulence; some might be effective for challenge in vaccine efficacy studies, while other, of lower virulence, may be vaccine candidates for use in water buffalo.

Cows (n = 21), dried off for a minimum of 45 days, and nulliparous heifers (n = 26), at ages > 18 months old, were placed on a 12-day Lactation Induction (LI) protocol. One group of animals (including both cows and heifers) received 3-minute mammary gland stimulation, along with the LI protocol. Another group, again including both cows and heifers, received no stimulation. Only the LI protocol consisted of two injections of prostaglandin F2α (PGF2α; 25 mg) 11 days apart, followed by subcutaneous injections of 17ß-estradiol (0.1 mg/kg BW/d) and progesterone (0.25 mg/kg BW/d) beginning 1 day later and continuing for seven (7) days. After this step, all animals received another injection of PGF2α on day 8, followed by intramuscular injections of reserpine (5 mg/d) and dexamethasone (20 mg/d) on each of days 9 to 12. All animals were milked, beginning on day 13, for a period of 154 days. For all animals, the success rate for lactation induction was 78% ± 6.3% and the mean weekly milk yield was 78.2 kg. Neither value was affected by mammary stimulation. Parity did not significantly impact on the success rate, but it did affect the mean weekly milk yield. Milk yield varied significantly (p < 0.001) with week, peaking during week 9. Peak milk production and persistency were 101.6 kg ± 5.9 kg and 16.9 weeks ± 2.4 weeks respectively, with neither being significantly (α = 0.05 level) affected by stimulation or by parity. However, heifers (at 8.2 weeks ± 1.0 week) tended (p = 0.1) to reach peak milk production earlier than cows (at 10.7 weeks ± 1.3). The milk produced was sold at a net profit per animal treated of $2206.31 TT. Hence, one can conclude that a Lactation Induction protocol can be a useful management tool to increase production and profitability of dairy operations in the tropics.

Thirty-two water buffalo (Bubalus bubalis) calves aged 6–10 months were used to evaluate serological responses to Brucella abortus strain RB51 (RB51) vaccination in a dose-response study and to compare the use of two selective media for the isolation of RB51. The animals were randomly divided into three treatment groups. Groups I-III received the recommended vaccine dose (RD) twice 4 weeks apart, RD twice 18 weeks apart and saline once, respectively. Lymph nodes were excised from the three groups and subjected to bacteriological examination to determine the frequency of detection of RB51. Pre- and post-vaccination blood samples were collected and tested for B. abortus antibodies using the buffered plate agglutination test (BPAT), complement fixation test (CFT), and dot-blot assay. Sera taken at all post-inoculation weeks (PIW) were negative for field strain B. abortus using the BPAT. Antibody responses to RB51 were demonstrated in all vaccinates but not in controls by CFT and dot-blot assay from 1 PIW up to 16 weeks following booster vaccination. The agreement for both assays was 80.7% and there was a linear interdependence with a Pearson's correlation coefficient value of 0.578. The frequency of isolation of RB51 from the two selective media used was not significantly different (P > 0.05).